T he article by Ferrara et al. 1 in this issue of Cancer describes the treatment of patients with poor prognosis myelodysplastic syndromes (MDS) using intensive remission induction chemotherapy followed by peripheral blood stem cell transplantation for patients age Ο½ 60 years. Thirty-two patients wi
β¦ LIBER β¦
Evolving treatment options of myelodysplastic syndromes
β Scribed by W. Verbeek; A. Ganser
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 70 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The treatment of the myelodysplastic syn
β
Harvey D. Preisler
π
Article
π
1999
π
John Wiley and Sons
π
English
β 67 KB
π 2 views
Pathogenesis, classification, and treatm
β
Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R. Sperr; Klaus Gei
π
Article
π
2003
π
Springer Vienna
π
English
β 225 KB
Current status of epigenetic treatment i
β
Andrea Kuendgen; Michael LΓΌbbert
π
Article
π
2008
π
Springer
π
English
β 206 KB
A strategy for erythropoietin treatment
β
R Hast
π
Article
π
1999
π
Springer US
π
English
β 274 KB
Myelodysplastic syndrome evolving to a m
β
Dr. J. F. San Miguel; M. Gonzalez; M. C. Del Caβtizo; A. LΓ³pez-Borrasca
π
Article
π
1986
π
John Wiley and Sons
π
English
β 147 KB
Treatment of myelodysplastic syndromes w
β
Spitzer, Thomas R. ;Lazarus, Hillard M. ;Crum, Edward D. ;Weisman, Russell
π
Article
π
1988
π
John Wiley and Sons
π
English
β 374 KB
Several cytotoxic agents when used in vitro in very low concentrations have been shown to induce differentiation of leukemic cells. We treated 18 patients with rnyelodysplastic syndromes with lowdose oral 6-thioguanine (6-TG; 20 to 60 rng daily). Four patients demonstrated significant improvement in